New Chewing Gum Shows Promise in Combating Oral HPV and Potentially Treating Oral Cancer
Researchers in New York are developing a chewing gum, derived from lablab beans, that has shown a 93% effectiveness in combating oral HPV and potentially treating oral cancer.
New York, NY, August 15, 2026 —
Researchers in New York are developing a novel chewing gum with the potential to combat oral human papillomavirus (HPV) and aid in the treatment of oral cancer. The chewing gum is derived from lablab beans, a type of legume.
Early research indicates that the chewing gum formulation has demonstrated a remarkable 93% effectiveness in combating oral HPV. This development could represent a significant advancement in addressing a virus that is a known risk factor for several types of cancer, including oral cancer.
The project is currently in the research and development phase. The specific details regarding the timeline for further testing, regulatory approvals, or availability to the public were not provided. The exact mechanisms by which the lablab bean-derived compound in the gum neutralizes the virus or affects cancerous cells are still under investigation by the research team.
Oral HPV infections are a significant public health concern, and effective preventative or therapeutic strategies are actively sought. If the reported effectiveness of this chewing gum holds true in further studies, it could offer a new and potentially accessible method for managing oral HPV and its associated health risks.
The contractor’s name was not provided. The fine amount was not provided.
Story summarized from the original created by Trista Panagakos on nypost.com, see more information here.
